OMER OMEROS CORP Operational Disruptions 8-K Filing 2023 - Phase 3 Trial Results Omeros Corporation announced results from the Phase 3 ARTEMIS-IGAN trial for the treatment of IgA nephropathy.Get access to all SEC 8-K filings of the OMEROS CORP